Difference between revisions of "Celecoxib"

(Text replacement - "0 mg" to "0mg")
(Mechanism of Action: added mechanism)
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
==Administration==
 
==Administration==
 
*Type: [[Nonsteroidal anti-inflammatory drugs]] (NSAID), COX-2 Selective
 
*Type: [[Nonsteroidal anti-inflammatory drugs]] (NSAID), COX-2 Selective
*Dosage Forms: 50,100,200,400
+
*Dosage Forms: capsule
*Routes of Administration: Oral
+
*Dosage Strengths: 50, 100, 200, 400mg
*Common Trade Names: CeleBREX
+
*Routes of Administration: PO
 +
*Common Trade Names: Celebrex
  
 
==Adult Dosing==
 
==Adult Dosing==
*[[Osteoarthritis]]: 200mg PO qd
+
*[[Osteoarthritis]]: 200mg PO QD
  
 
*[[Rheumatoid arthritis]]: 100-200mg PO bid
 
*[[Rheumatoid arthritis]]: 100-200mg PO bid
Line 12: Line 13:
 
**Consider starting at 50% of lowest dose if poor CYP2C9 metabolizer
 
**Consider starting at 50% of lowest dose if poor CYP2C9 metabolizer
  
*[[Ankylosing spondylitis]]: 200mg PO qd
+
*[[Ankylosing spondylitis]]: 200mg PO QD
 
**Max: 400mg/day
 
**Max: 400mg/day
  
Line 68: Line 69:
  
 
==Mechanism of Action==
 
==Mechanism of Action==
 +
Inhibits cyclooxygenase (COX)-2; does not affect COX-1 (at therapeutic concentrations), thereby decreasing formation of prostaglandin synthesis
  
 
==Comments==
 
==Comments==

Latest revision as of 18:33, 13 October 2017

Administration

  • Type: Nonsteroidal anti-inflammatory drugs (NSAID), COX-2 Selective
  • Dosage Forms: capsule
  • Dosage Strengths: 50, 100, 200, 400mg
  • Routes of Administration: PO
  • Common Trade Names: Celebrex

Adult Dosing

  • Rheumatoid arthritis: 100-200mg PO bid
    • Use lowest effective dose, shortest effective treatment duration
    • Consider starting at 50% of lowest dose if poor CYP2C9 metabolizer
  • Dysmenorrhea: 200mg PO bid
    • Start: 400mg PO x1, may give additional 200mg on day 1 if needed
  • Pain, acute: 200mg PO bid
    • Start: 400mg PO x1, may give additional 200mg on day 1 if needed

Pediatric Dosing

Only for ages > 2 years old

Special Populations

Renal Dosing

  • Avoid use in severe renal impairment

Hepatic Dosing

  • Adult:Child-Pugh Class B: decrease dose 50%; Child-Pugh Class C: avoid use

Contraindications

  • hypersens. to drug/class/compon.
  • hypersens. to sulfonamides
  • ASA or NSAID-induced asthma or urticaria
  • aspirin triad
  • pregnancy starting at 30 wk gestation
  • CABG surgery periop use
  • GI bleeding

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life: 11hr
  • Metabolism: CYP450
  • Excretion: feces, urine

Mechanism of Action

Inhibits cyclooxygenase (COX)-2; does not affect COX-1 (at therapeutic concentrations), thereby decreasing formation of prostaglandin synthesis

Comments

See Also

References

<Epocrates, UpToDate>